(Press-News.org) In monkeys and humans with AIDS, damage to the gastrointestinal tract is common, contributing to activation of the immune system, progressive immune deficiency, and ultimately advanced AIDS. How this gastric damage occurs has remained a mystery, but now researchers reporting in the Cell Press journal Cell provide new clues, implicating the presence of potentially pathogenic virus species other than the main virus that causes AIDS. The findings could provide an opportunity to explain and eventually intervene in the processes that lead to AIDS progression.
To investigate what causes gastrointestinal damage in monkeys and humans with AIDS, researchers used a sequencing method that allows them to obtain genetic sequences of all of the bacterial, viral, and other organisms residing in the gastrointestinal tract. Using this technique, they examined the feces of monkeys with SIV-induced AIDS, monkeys without SIV infection, and monkeys infected with SIV strains that do not cause AIDS. (SIV is the monkey counterpart to HIV.)
"We found that the gastrointestinal tract of the animals with AIDS contained a large number of previously undescribed viruses—including potential pathogens, but we did not see any obvious changes in the bacteria. This means that previously unrecognized viruses may contribute to AIDS disease progression in monkeys," explains co-author Dr. Dan Barouch, of Harvard Medical School and the Beth Israel Deaconess Medical Center, in Boston. It's not clear why monkeys with AIDS have more intestinal viruses, but it may be related to their compromised immune system.
The researchers also noted that some of the viruses in the feces of monkeys with AIDS were also found circulating in the animals' blood. In addition, many were RNA viruses, meaning that their genetic material is made up of RNA rather than DNA. "This is the first time anyone has looked at both DNA- and RNA-based organisms in the fecal matter in association with AIDS. The striking finding of so many RNA viruses to go along with DNA viruses opens up the broader issue of whether we need to rethink how we study the genomes of microorganisms that may affect disease," says senior author Dr. Herbert Virgin, of the Washington University School of Medicine, in Saint Louis.
In addition to providing new information on how AIDS advances, and therefore how to potentially intervene to slow it down, the results indicate that the viruses found in AIDS patients' intestines could indicate how progressive their disease will be.
###
Handley et al.: "Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome."
Diverse intestinal viruses may play a role in AIDS progression
2012-10-11
ELSE PRESS RELEASES FROM THIS DATE:
Stopping the itch -- new clues into how to treat eczema
2012-10-11
More than 15% of children suffer with eczema, or atopic dermatitis, an inflammatory skin disease that in some cases can be debilitating and disfiguring. Researchers reporting in the October issue of Immunity have discovered a potential new target for the condition, demonstrating that by blocking it, they can lessen the disease in mice.
In eczema, immune T cells invade the skin and secrete factors that drive an allergic response, making the skin itch. Dr. Raif Geha, of Boston Children's Hospital, and his collaborators now show that scratching the skin precipitates the ...
New report calls for global efforts to prevent fragility fractures due to osteoporosis
2012-10-11
Today, the International Osteoporosis Foundation (IOF) released a new report, revealing approximately 80 percent of patients treated in clinics or hospitals following a fracture are not screened for osteoporosis or risk of future falls. Left untreated, these patients are at high risk of suffering secondary fractures and facing a future of pain, disfigurement, long-term disability and even early death.
The report 'Capture the Fracture – A global campaign to break the fragility fracture cycle' calls for concerted worldwide efforts to stop secondary fractures due to osteoporosis ...
Target for obesity drugs comes into focus
2012-10-11
ANN ARBOR—Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.
Leptin is a hormone secreted by fat tissue that has been of interest for researchers in obesity and Type 2 diabetes since it was discovered in 1995. Like insulin, leptin is part of a regulatory network that controls intake and expenditure of energy in the body, and a lack of leptin or resistance to it has been linked to obesity in people.
Although there can be several complex reasons ...
Large international study finds 21 genes tied to cholesterol levels
2012-10-11
In the largest-ever genetic study of cholesterol and other blood lipids, an international consortium has identified 21 new gene variants associated with risks of heart disease and metabolic disorders. The findings expand the list of potential targets for drugs and other treatments for lipid-related cardiovascular disease, a leading global cause of death and disability.
The International IBC Lipid Genetics Consortium used the Cardiochip, a gene analysis tool invented by Brendan J. Keating, Ph.D., a scientist at the Center for Applied Genomics at The Children's Hospital ...
Feeding the Schwanns: New technique could bring cell therapy for nerve damage a step closer
2012-10-11
A new way to grow cells vital for nerve repair, developed by researchers from the University of Sheffield, could be a vital step for use in patients with severe nerve damage, including spinal injury (1).
Schwann cells are known to boost and amplify nerve growth in animal models, but their clinical use has been held back because they are difficult, time-consuming and costly to culture.
The Sheffield team, led by Professor John Haycock, has developed a new technique with adult rat tissue which overcomes all these problems, producing Schwann cells in less than half the time ...
New tool determines leukemia cells' 'readiness to die,' may guide clinical care
2012-10-11
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more effectively for their patients who have AML.
In a study published in the Oct. 12 issue of the journal Cell, the researchers report that their findings may lead to improved tests to predict which patients successfully treated for AML can continue in remission with standard chemotherapy alone, and which patients are likely to relapse despite ...
Nearby super-Earth likely a diamond planet
2012-10-11
New Haven, Conn. — New research led by Yale University scientists suggests that a rocky planet twice Earth's size orbiting a nearby star is a diamond planet.
"This is our first glimpse of a rocky world with a fundamentally different chemistry from Earth," said lead researcher Nikku Madhusudhan, a Yale postdoctoral researcher in physics and astronomy. "The surface of this planet is likely covered in graphite and diamond rather than water and granite."
The paper reporting the findings has been accepted for publication in the journal Astrophysical Journal Letters.
The ...
A new cave-dwelling reef coral discovered in the Indo-Pacific
2012-10-11
Coral specialist Dr. Bert W. Hoeksema of Naturalis Biodiversity Center in Leiden, The Netherlands, recently published the description of a new coral species that lives on the ceilings of caves in Indo-Pacific coral reefs. It differs from its closest relatives by its small polyp size and by the absence of symbiotic algae, so-called zooxanthellae. Its distribution range overlaps with the Coral Triangle, an area that is famous for its high marine species richness. Marine zoologists of Naturalis visit this area frequently to explore its marine biodiversity.
Reef corals in ...
How food marketers can help consumers eat better while improving their bottom line
2012-10-11
Food marketers are masters at getting people to crave and consume the foods that they promote. In this study authors Dr. Brian Wansink, co-director of the Cornell University Center for Behavioral Economics in Child Nutrition and Professor of Marketing and Dr. Pierre Chandon, professor of Marketing at the leading French graduate school of business, INSEAD challenge popular assumptions that link food marketing and obesity. Their findings presented last weekend at the Association for Consumer Research Conference in Vancouver, Canada point to ways in which smart food marketers ...
Research gives new insight into celiac disease
2012-10-11
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
Published today in Immunity, the discovery was led by Dr Hugh Reid and Professor Jamie Rossjohn of Monash University, Professor Frits Koning of the University of Leiden and Dr Bob Anderson of biotechnology company ImmusanT Inc, based in the US.
An increasingly diagnosed chronic inflammatory disorder, coeliac disease affects the digestive process of the small ...